IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 161 filers reported holding IMPAX LABORATORIES INC in Q3 2014. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,030,000 | +16.8% | 104,360 | 0.0% | 0.01% | +25.0% |
| Q4 2017 | $1,738,000 | -17.8% | 104,360 | +0.2% | 0.00% | -20.0% |
| Q3 2017 | $2,114,000 | +26.1% | 104,160 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $1,677,000 | +27.5% | 104,160 | +0.2% | 0.00% | +33.3% |
| Q1 2017 | $1,315,000 | -4.5% | 103,960 | 0.0% | 0.00% | -25.0% |
| Q4 2016 | $1,377,000 | -43.7% | 103,960 | +0.8% | 0.00% | -33.3% |
| Q3 2016 | $2,445,000 | -23.9% | 103,160 | -7.4% | 0.01% | -25.0% |
| Q2 2016 | $3,212,000 | -4.5% | 111,460 | +6.1% | 0.01% | -11.1% |
| Q1 2016 | $3,364,000 | -25.1% | 105,060 | 0.0% | 0.01% | -25.0% |
| Q4 2015 | $4,492,000 | +25.3% | 105,060 | +3.1% | 0.01% | +20.0% |
| Q3 2015 | $3,586,000 | -22.1% | 101,860 | +1.6% | 0.01% | -16.7% |
| Q2 2015 | $4,602,000 | +28.5% | 100,210 | +31.2% | 0.01% | +33.3% |
| Q1 2015 | $3,581,000 | +23.4% | 76,400 | -16.6% | 0.01% | +125.0% |
| Q4 2014 | $2,902,000 | +243.0% | 91,600 | +156.6% | 0.00% | +100.0% |
| Q3 2014 | $846,000 | -14.0% | 35,700 | +8.8% | 0.00% | -33.3% |
| Q2 2014 | $984,000 | +16.0% | 32,800 | +2.2% | 0.00% | +50.0% |
| Q1 2014 | $848,000 | +0.1% | 32,100 | -4.7% | 0.00% | 0.0% |
| Q4 2013 | $847,000 | +12.5% | 33,700 | -8.4% | 0.00% | 0.0% |
| Q3 2013 | $753,000 | -0.7% | 36,800 | -3.2% | 0.00% | 0.0% |
| Q2 2013 | $758,000 | – | 38,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |